Key result
Modified management algorithm linked to improved 3-month electroclinical remission in infantile epileptic spasms syndrome.
Why the study?
Clinical variables that determine treatment response for infantile epileptic spasms syndrome are unknown, and identifying modifiable variables could inform treatment decisions.
Does a modified management algorithm including early hormone treatment improve 3-month electroclinical remission in children with infantile epileptic spasms syndrome?
Cohort
Does a modified management algorithm including early hormone treatment improve 3-month electroclinical remission in children with infantile epileptic spasms syndrome?
Answers are grounded in this paper and cite their sources.
Suggests early hormone treatment may optimize remission in infantile spasms, but should not yet.
Clinical variables that determine the response to treatment for infantile epileptic spasms syndrome (IESS) are unknown. The identification of variables that can be modified would inform treatment decisions. The objective of this retrospective consecutive sample cohort study was to develop a predictive model for 3-month electroclinical remission. In May 2019, we modified our IESS management algorithm to include hormone as first treatment and second treatment within 14 days for initial nonresponders. We hypothesized that children who received care consistent with this algorithm would have a higher rate of 3-month remission.
No takes yet. Share an insight, caveat, or question.
Mytinger et al. (2025) conducted a cohort in Infantile epileptic spasms syndrome (IESS). Modified IESS management algorithm was evaluated on 3-month electroclinical remission.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: